EDA3 20056.86 pg/mL, IQR 12573.71–30082.41; median of active progressive MS 19302.28 pg/mL, IQR 17358.62–28659.20; median of active AE 3082.10, IQR 1380.97–12526.44; p = 0.155) showed no significant differences, the cNfL/cGFAP ratio successfully separated AE from stable MS patients and controls but barely missed statistical significance in separating AE from active progressive MS patients (median of controls 0.047, IQR 0.034–0.052; median of MS NEDA3 0.06, IQR 0.04–0.12; median of active progressive MS 0.06, IQR 0.06–0.07; median of active AE 0.406, IQR 0.145–1.037; active AE vs. controls p < 0.001; active AE vs.
← all excerpts
Glial Fibrillary Acid Protein Reflects Disease Activity in Autoimmune Encephalitis.
1
—
—